These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21139487)

  • 1. Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 years.
    Soulie C; Lambert-Niclot S; Wirden M; Simon A; Valantin MA; Fourati S; Tubiana R; Katlama C; Calvez V; Marcelin AG
    AIDS; 2011 Feb; 25(4):537-9. PubMed ID: 21139487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
    Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two genotypic algorithms to determine HIV-1 tropism.
    Soulié C; Derache A; Aimé C; Marcelin AG; Carcelain G; Simon A; Katlama C; Calvez V
    HIV Med; 2008 Jan; 9(1):1-5. PubMed ID: 18199166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
    Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
    AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variability in HIV viral tropism determination using different genotypic algorithms in patients infected with B versus non-B HIV-1 subtypes].
    Rodríguez JJ; Seclén E; Poveda E; Varela E; Regueiro B; Aguilera A
    Enferm Infecc Microbiol Clin; 2011 Jan; 29(1):4-8. PubMed ID: 21310511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals.
    Braun P; Wiesmann F
    Eur J Med Res; 2007 Oct; 12(9):463-72. PubMed ID: 17933728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV coreceptor tropism in antiretroviral treatment-naive patients newly diagnosed at a late stage of HIV infection.
    Simon B; Grabmeier-Pfistershammer K; Rieger A; Sarcletti M; Schmied B; Puchhammer-Stöckl E
    AIDS; 2010 Aug; 24(13):2051-8. PubMed ID: 20601851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.
    Svicher V; D'Arrigo R; Alteri C; Andreoni M; Angarano G; Antinori A; Antonelli G; Bagnarelli P; Baldanti F; Bertoli A; Borderi M; Boeri E; Bonn I; Bruzzone B; Callegaro AP; Cammarota R; Canducci F; Ceccherini-Silberstein F; Clementi M; Monforte AD; De Luca A; Di Biagio A; Di Gianbenedetto S; Di Perri G; Di Pietro M; Fabeni L; Fadda G; Galli M; Gennari W; Ghisetti V; Giacometti A; Gori A; Leoncini F; Maggiolo F; Maserati R; Mazzotta F; Micheli V; Meini G; Monno L; Mussini C; Nozza S; Paolucci S; Parisi S; Pecorari M; Pizzi D; Quirino T; Re MC; Rizzardini G; Santangelo R; Soria A; Stazi F; Sterrantino G; Turriziani O; Viscoli C; Vullo V; Lazzarin A; Perno CF;
    New Microbiol; 2010 Jul; 33(3):195-206. PubMed ID: 20954437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy.
    Masquelier B; Capdepont S; Neau D; Peuchant O; Taupin JL; Coakley E; Lie Y; Carpentier W; Dabis F; Fleury HJ;
    AIDS; 2007 Jan; 21(1):103-6. PubMed ID: 17148975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of C-C chemokine receptor type 5 tropism among human immunodeficiency virus 1-infected patients in South Korea.
    Song JE; Ahn MY; Kim WJ; Kim SW; Lee JS; Ku NS; Kim JH; Kim KH; Ann H; Choi JY
    J Med Virol; 2018 Nov; 90(11):1720-1723. PubMed ID: 29981165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.
    Svicher V; Alteri C; Montano M; D'Arrigo R; Andreoni M; Angarano G; Antinori A; Antonelli G; Allice T; Bagnarelli P; Baldanti F; Bertoli A; Borderi M; Boeri E; Bon I; Bruzzone B; Callegaro AP; Capobianchi MR; Carosi G; Cauda R; Ceccherini-Silberstein F; Clementi M; Chirianni A; Colafigli M; D'Arminio Monforte A; De Luca A; Di Biagio A; Di Nicuolo G; Di Perri G; Di Pietro M; Di Santo F; Fabeni L; Fadda G; Galli M; Gennari W; Ghisetti V; Giacometti A; Gori C; Gori A; Gulminetti R; Leoncini F; Maffongelli G; Maggiolo F; Manca G; Gargiulo F; Martinelli C; Maserati R; Mazzotta F; Meini G; Micheli V; Monno L; Mussini C; Narciso P; Nozza S; Paolucci S; Pal G; Parisi S; Parruti G; Pignataro AR; Pollicita M; Quirino T; Re MC; Rizzardini G; Santangelo R; Scaggiante R; Sterrantino G; Turriziani O; Vatteroni ML; Vecchi L; Viscoli C; Vullo V; Zazzi M; Lazzarini A; Perno CF;
    New Microbiol; 2012 Jan; 35(1):17-25. PubMed ID: 22378549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains.
    Chalmet K; Van Wanzeele F; Demecheleer E; Dauwe K; Pelgrom J; Van Der Gucht B; Vogelaers D; Plum J; Stuyver L; Vandekerckhove L; Verhofstede C
    Virology; 2008 Sep; 379(2):213-22. PubMed ID: 18692212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia.
    Seclén E; Del Mar González M; De Mendoza C; Soriano V; Poveda E
    J Antimicrob Chemother; 2010 Jul; 65(7):1493-6. PubMed ID: 20488982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
    Raymond S; Delobel P; Izopet J
    J Antimicrob Chemother; 2010 Sep; 65(9):2056-7; author reply 2058-9. PubMed ID: 20554569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.